Samyag

Corporate Actions

Back

Hester Biosciences to divest over 43% stake in Texas Lifesciences for Rs 9.2 crore

11-Mar-26 14:30 Hrs IST

The company's currently holds around 54.81% stake in Texas Lifesciences.

Texas Lifesciences had recorded a turnover of Rs 28.59 crore and its net worth was Rs 13.41 crore in FY2024-25.

Offering details of this transaction, the company stated that the 43.81% shareholding of Hester will be transferred to Ticop Life, an entity affiliated to the existing promoter shareholders of TLPL.

Hester will continue to do business with TLPL and maintain an 11% equity stake in the company.

The company expects to conclude this transaction within a period of three months from the date of this agreement. It will receive a consideration of Rs 9.2 crore as a part of this transaction.

Hester Biosciences Limited is one of the India's leading animal health company, manufacturing vaccines and health products. It is the second largest poultry vaccine manufacturer, with approximately 35% market share in India.

The company had reported 24.79% fall in consolidated net profit to Rs 8.77 crore despite a 22.46% increase in revenue to Rs 77.42 crore in Q3 FY26 as compared with Q3 FY25.

The scrip fell 0.17% to currently trade at Rs 1450.00 on the BSE.

Powered by Capital Market - Live News

Attention Investors: Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.|| KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.|| No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.